Page last updated: 2024-08-21

isoxazoles and Movement Disorders

isoxazoles has been researched along with Movement Disorders in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Havaki-Kontaxaki, B; Karaiskos, D; Papadimitriou, GN; Pappa, D1
Kumar, A; Mishra, J1
Lerner, PP; Lerner, V; Miodownik, C1
Lai, CH1
Irie, S; Iwashita, S; Iwata, Y; Mimura, M; Suzuki, T; Uchida, H; Watanabe, K1
Bae, KY; Chung, YC; Kim, JM; Kim, SW; Kim, SY; Lee, JH; Lee, YH; Shin, IS; Yoon, JS1

Reviews

1 review(s) available for isoxazoles and Movement Disorders

ArticleYear
Tardive dyskinesia (syndrome): Current concept and modern approaches to its management.
    Psychiatry and clinical neurosciences, 2015, Volume: 69, Issue:6

    Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; alpha-Tocopherol; Amantadine; Anticonvulsants; Antioxidants; Antipsychotic Agents; Clonazepam; Dopamine Agents; Drugs, Chinese Herbal; Fatty Acids, Omega-3; Ginkgo biloba; Humans; Isoleucine; Isoxazoles; Leucine; Levetiracetam; Melatonin; Movement Disorders; Nootropic Agents; Piracetam; Plant Extracts; Propranolol; Pyridoxine; Resveratrol; Stilbenes; Tetrabenazine; Valine; Vitamins; Zonisamide

2015

Trials

2 trial(s) available for isoxazoles and Movement Disorders

ArticleYear
Effects of zonisamide on tardive dyskinesia: a preliminary open-label trial.
    Journal of the neurological sciences, 2012, Apr-15, Volume: 315, Issue:1-2

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Female; Humans; Isoxazoles; Male; Movement Disorders; Treatment Outcome; Zonisamide

2012
Paliperidone ER versus risperidone for neurocognitive function in patients with schizophrenia: a randomized, open-label, controlled trial.
    International clinical psychopharmacology, 2012, Volume: 27, Issue:5

    Topics: Adolescent; Adult; Antipsychotic Agents; Cognition Disorders; Delayed-Action Preparations; Depression; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Monitoring; Female; Humans; Isoxazoles; Male; Middle Aged; Movement Disorders; Paliperidone Palmitate; Prevalence; Psychiatric Status Rating Scales; Pyrimidines; Republic of Korea; Risperidone; Schizophrenia; Young Adult

2012

Other Studies

3 other study(ies) available for isoxazoles and Movement Disorders

ArticleYear
Paliperidone-induced tardive dystonia: a case report.
    The Journal of neuropsychiatry and clinical neurosciences, 2013,Spring, Volume: 25, Issue:2

    Topics: Adult; Antipsychotic Agents; Female; Humans; Isoxazoles; Movement Disorders; Paliperidone Palmitate; Pyrimidines; Schizophrenia

2013
Improvement of mitochondrial function by paliperidone attenuates quinolinic acid-induced behavioural and neurochemical alterations in rats: implications in Huntington's disease.
    Neurotoxicity research, 2014, Volume: 26, Issue:4

    Topics: Acetylcholinesterase; Animals; Biogenic Amines; Body Weight; Corpus Striatum; Huntington Disease; Isoxazoles; Male; Maze Learning; Memory Disorders; Mitochondria; Movement Disorders; Neurons; Neuroprotective Agents; Oxidative Stress; Oxygen; Paliperidone Palmitate; Pyrimidines; Quinolinic Acid; Rats, Wistar

2014
Improvement of oral dyskinesia after switching from aripiprazole to paliperidone: a case report.
    The Journal of neuropsychiatry and clinical neurosciences, 2011,Summer, Volume: 23, Issue:3

    Topics: Antipsychotic Agents; Aripiprazole; Female; Humans; Isoxazoles; Movement Disorders; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Schizophrenia

2011